This paper is in the following e-collection/theme issue:

Research Instruments, Questionnaires, and Tools (456)

Published on in Vol 23 , No 7 (2021) :July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27633, first published .
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Authors of this article:

András Lánczky 1, 2 Author Orcid Image ;   Balázs Győrffy 1, 2 Author Orcid Image
Article Authors Cited by (415) Tweetations (7) Metrics

Journals

  1. Soares-Lima S, Gonzaga I, Camuzi D, Nicolau-Neto P, Vieira da Silva R, Guaraldi S, Ferreira M, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto L. IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 2021;11 View
  2. Mikaeili Namini A, Jahangir M, Mohseni M, Kolahi A, Hassanian-Moghaddam H, Mazloumi Z, Motallebi M, Sheikhpour M, Movafagh A. An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC). Scientific Reports 2022;12(1) View
  3. Nelczyk A, Ma L, Gupta A, Gamage H, McHenry M, Henn M, Kadiri M, Wang Y, Krawczynska N, Bendre S, He S, Shahoei S, Madak-Erdogan Z, Hsiao S, Saleh T, Carpenter V, Gewirtz D, Spinella M, Nelson E. The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868(11):166515 View
  4. Iqbal M, Ahmad N, Mirza Z, Karim S. Gene expression and survival analysis study of KIAA0101 gene revealed its prognostic and diagnostic importance in breast cancer. Vegetos 2023;36(1):249 View
  5. Nishimura T, Takadate T, Maeda S, Suzuki T, Minowa T, Fukuda T, Bando Y, Unno M. Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma. Scientific Reports 2022;12(1) View
  6. Wei M, Mo Y, Liu J, Zhai J, Li H, Xu Y, Peng Y, Tang Z, Wei T, Yang X, Huang L, Shao X, Li J, Zhou L, Zhong H, Wei C, Xie Q, Min M, Wu F. Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation. Frontiers in Oncology 2022;12 View
  7. Ucche S, Yokoyama S, Mojic M, Oki K, Ohshima C, Tsuihiji H, Takasaki I, Tahara H, Hayakawa Y. GSTA4 Governs Melanoma Immune Resistance and Metastasis. Molecular Cancer Research 2023;21(1):76 View
  8. Yang Y, Chen C, Zuo Q, Lu H, Salman S, Lyu Y, Huang T, Wicks E, Jackson W, Datan E, Wang R, Wang Y, Le N, Zhu Y, Qin W, Semenza G. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science Advances 2022;8(49) View
  9. Ma J, Song P, Liu X, Ma C, Zheng M, Ren X, Wang R, Liu W, Lu Z, Li J. Insights into the roles and driving forces of CCT3 in human tumors. Frontiers in Pharmacology 2022;13 View
  10. Zhang P, Zhao J, Chen L, Bian Z, Ju L, Wang H, Cai W. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. BMC Gastroenterology 2023;23(1) View
  11. Chen X, Han M, Li Y, Li X, Zhang J, Zhu Y. Identification of functional gene modules by integrating multi-omics data and known molecular interactions. Frontiers in Genetics 2023;14 View
  12. Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, Wang C, Liang G, Li Y. The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer. Journal of Oncology 2023;2023:1 View
  13. Purazo M, Ice R, Shimpi R, Hoenerhoff M, Pugacheva E. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers 2023;15(4):1119 View
  14. Song X, Li J, Pietras R. Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  15. Chen W, Wang H, Mi S, Shao L, Xu Z, Xue M. ALKBH1 ‐mediated m 1 A demethylation of METTL3 mRNA promotes the metastasis of colorectal cancer by downregulating SMAD7 expression. Molecular Oncology 2023;17(2):344 View
  16. Shen C, Chang W, Chen Y, Weng C, Regmi P, Kier M, Su K, Chang G, Chen J, Chen Y, Yu S. Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma. Journal of Proteome Research 2023;22(4):1056 View
  17. Petkevicius V, Thon C, Steponaitiene R, Skieceviciene J, Janciauskas D, Jechorek D, Malfertheiner P, Kupcinskas J, Link A. Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer. Clinical and Translational Gastroenterology 2022;13(5):e00483 View
  18. Prieto‐Garcia C, Hartmann O, Reissland M, Braun F, Bozkurt S, Pahor N, Fuss C, Schirbel A, Schülein‐Völk C, Buchberger A, Calzado Canale M, Rosenfeldt M, Dikic I, Münch C, Diefenbacher M. USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. Molecular Oncology 2022;16(17):3082 View
  19. Zhao Y, Zuo J, Shen Y, Yan D, Chen J, Qi X. Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis. Symmetry 2022;14(7):1403 View
  20. Zhang J, Li Y, Zou J, Lai C, Zeng T, Peng J, Zou W, Cao B, Liu D, Zhu L, Li H, Li Y. Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance. Frontiers in Oncology 2022;12 View
  21. Qi Y, Zhang C, Wu D, Zhang Y, Zhao Y, Li W. Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells. Pharmaceuticals 2022;15(10):1257 View
  22. Beltrán-Navarro Y, Reyes-Cruz G, Vázquez-Prado J. P-Rex1 Signaling Hub in Lower Grade Glioma Patients, Found by In Silico Data Mining, Correlates With Reduced Survival and Augmented Immune Tumor Microenvironment. Frontiers in Oncology 2022;12 View
  23. Gao S, Zhang H, Lai L, Zhang J, Li Y, Miao Z, Rahman S, Zhang H, Qian A, Zhang W. S100A10 might be a novel prognostic biomarker for head and neck squamous cell carcinoma based on bioinformatics analysis. Computers in Biology and Medicine 2022;149:106000 View
  24. Han M, Li Y, Guo Y, Zhu W, Jiang J. Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors. International Journal of Molecular Sciences 2022;23(22):13998 View
  25. Wang M, Qiu Z, Wang Y, Lian B, Bai J, Zhou Y, Ji H. Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma. BMC Cancer 2023;23(1) View
  26. Criscuolo D, Avolio R, Parri M, Romano S, Chiarugi P, Matassa D, Esposito F. Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer. Antioxidants 2022;11(8):1544 View
  27. Zhang Z, Wang Z, Liu Y, Zhao L, Fu W. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Journal of Environmental Pathology, Toxicology and Oncology 2023;42(2):11 View
  28. Wang L, Zhao J, Zhu C, Yang K, Zhu L, Liu Y. Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma. Genes 2022;13(5):785 View
  29. Raivola J, Dini A, Karvonen H, Piki E, Salokas K, Niininen W, Kaleva L, Zhang K, Arjama M, Gudoityte G, Seashore-Ludlow B, Varjosalo M, Kallioniemi O, Hautaniemi S, Murumägi A, Ungureanu D. Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention. Cell Death & Disease 2022;13(8) View
  30. Liu K, Cui L, Li C, Tang C, Niu Y, Hao J, Bu Y, Chen B. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker. Frontiers in Genetics 2022;13 View
  31. Hu Y, Xie Q, Wu X, Liu W, Li D, Li C, Zhao W, Chen L, Zheng Z, Li G, Guo J. Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration. Cell Death & Disease 2022;13(10) View
  32. Stafford M, McKenna D. MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. International Journal of Molecular Sciences 2023;24(3):1824 View
  33. Liu Y, Fang Y, Bao L, Wu F, Wang S, Hao S. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. Biomolecules 2022;12(10):1478 View
  34. Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M, Dutt A. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. Breast Cancer Research 2022;24(1) View
  35. Xu Y, Zhang M, Shi Q, Cheng X, Du R, Li C, Zhang Y. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis. European Journal of Medical Research 2023;28(1) View
  36. Matassa D, Criscuolo D, Avolio R, Agliarulo I, Sarnataro D, Pacelli C, Scrima R, Colamatteo A, Matarese G, Capitanio N, Landriscina M, Esposito F. Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells. Cancer Cell International 2022;22(1) View
  37. Zhang X, Zhang Q, Liu G. Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance. Frontiers in Genetics 2022;13 View
  38. Sudha B, Swathi K, Suganya K, Poornima A, Senthil Kumar N, Sumathi S. Identification of Key Candidate Genes in the Progression of Cervical Cancer: An in Silico Analysis. Indian Journal of Gynecologic Oncology 2022;20(4) View
  39. Eid R, Soltan M, Eldeen M, Shati A, Dawood S, Eissa M, Zaki M, Algahtani M, Theyab A, Abdel-Daim M, Kim B. Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. International Journal of Molecular Sciences 2022;23(22):14102 View
  40. Ji K, Dou W, Zhang N, Wen B, Zhong M, Zhang Q, Xu S, Zhou J, Liu J. Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells. Cell Biology International 2023;47(1):144 View
  41. Madgwick S, Luli S, Sellier H, Butterworth J, Leslie J, Moore A, Corbin E, Yemm A, Chiremba R, Tiniakos D, Oakley F, Perkins N, Hunter J. Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential. Biochemical Journal 2022;479(19):2115 View
  42. Benwell C, Johnson R, Taylor J, Price C, Robinson S. Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis. Cancer Research Communications 2022;2(12):1626 View
  43. Huang P, Xia L, Guo Q, Huang C, Wang Z, Huang Y, Qin S, Leng W, Li D. Genome-wide association studies identify miRNA-194 as a prognostic biomarker for gastrointestinal cancer by targeting ATP6V1F, PPP1R14B, BTF3L4 and SLC7A5. Frontiers in Oncology 2022;12 View
  44. Yang Y, Qiu R, Zhao S, Shen L, Tang B, Weng Q, Xu Z, Zheng L, Chen W, Shu G, Wang Y, Zhao Z, Chen M, Ji J. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells. BMC Biology 2022;20(1) View
  45. Le Noci V, Bernardo G, Manenti G, Infante G, Khaleghi Hashemian D, Minoli L, Canesi S, Bianchi F, Triulzi T, Arioli S, De Cecco L, Guglielmetti S, Ambrogi F, Recordati C, Gagliano N, Tagliabue E, Sommariva M, Sfondrini L. Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model. International Journal of Molecular Sciences 2022;23(21):12748 View
  46. Liu Q, Xie R, Li Y. Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival. International Journal of Molecular Sciences 2022;23(17):9611 View
  47. Ye S, Li S, Qin L, Zheng W, Liu B, Li X, Ren Z, Zhao H, Hu X, Ye N, Li G. GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling. Oncology Reports 2023;49(3) View
  48. Shi S, Chen H, Wang H, Wan J, Shi Y, Li J, Wang S, Shi J, Lv J, Wu T, Wang L, Sun F. Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis. Journal of Cancer Research and Clinical Oncology 2022 View
  49. Wang S, Fu Y, Kuerban K, Liu J, Huang X, Pan D, Chen H, Zhu Y, Ye L. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. Frontiers in Immunology 2022;13 View
  50. Liu X, Chipurupalli S, Jiang P, Tavasoli M, Yoo B, McPhee M, Mazinani S, Francia G, Kerbel R, Rosen K. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth. Cell Death & Disease 2022;13(8) View
  51. Magallanes-Garza G, Santuario-Facio S, Lira-Albarrán S, Varela-Varela A, Cardona-Huerta S, Ruiz-Flores P, Haro-Santa-Cruz J, Perez-Paramo Y, Gomez-Macias G, Davila-Gonzalez D, Valero-Gomez J, Borrego-Soto G, Rojas-Martinez A, Ortiz-Lopez R, Li T. NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer. Journal of Oncology 2022;2022:1 View
  52. Wang R, Bhatt A, Minden-Birkenmaier B, Travis O, Tiwari S, Jia H, Rosikiewicz W, Martinot O, Childs E, Loesch R, Tossou G, Jamieson S, Finkelstein D, Xu B, Labelle M. ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis. Science Advances 2023;9(1) View
  53. Dwivedi K, Rajpal A, Rajpal S, Agarwal M, Kumar V, Kumar N. An explainable AI-driven biomarker discovery framework for Non-Small Cell Lung Cancer classification. Computers in Biology and Medicine 2023;153:106544 View
  54. Ko C, Chu T, Hsu C, Chen H, Huang S, Chang C, Tzou S, Chen T, Lin C, Shih P, Lin C, Chang C, Lee Y. Bioinformatics Analyses Identify the Therapeutic Potential of ST8SIA6 for Colon Cancer. Journal of Personalized Medicine 2022;12(3):401 View
  55. Chang Z, Duan Q, Yu C, Li D, Jiang H, Ge F, Xu G. Proteomics and Biochemical Analyses of Secreted Proteins Revealed a Novel Mechanism by Which ADAM12S Regulates the Migration of Gastric Cancer Cells. Journal of Proteome Research 2022;21(9):2160 View
  56. Bacon S, Seeneevassen L, Fratacci A, Rose F, Tiffon C, Sifré E, Haykal M, Moubarak M, Ducournau A, Bruhl L, Claverol S, Tokarski C, Gouloumi A, Pateras I, Daubon T, Lehours P, Varon C, Martin O. Nrf2 Downregulation Contributes to Epithelial-to-Mesenchymal Transition in Helicobacter pylori-Infected Cells. Cancers 2022;14(17):4316 View
  57. Cai Y, He Q, Liu W, Liang Q, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Peng J, Xu Z, Bai N. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Frontiers in Oncology 2022;12 View
  58. Zhang X, O’Brien D, Zhang X, Hussain T. Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  59. Ramos E, Tsai C, Jia Y, Cao Y, Manu M, Taftaf R, Hoffmann A, El-Shennawy L, Gritsenko M, Adorno-Cruz V, Schuster E, Scholten D, Patel D, Liu X, Patel P, Wray B, Zhang Y, Zhang S, Moore R, Mathews J, Schipma M, Liu T, Tokars V, Cristofanilli M, Shi T, Shen Y, Dashzeveg N, Liu H. Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. eLife 2022;11 View
  60. Schossig P, Coskun E, Arsenic R, Horst D, Sehouli J, Bergmann E, Andresen N, Sigler C, Busse A, Keller U, Ochsenreither S. Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences 2023;24(3):2292 View
  61. Boyero L, Noguera-Uclés J, Castillo-Peña A, Salinas A, Sánchez-Gastaldo A, Alonso M, Benedetti J, Bernabé-Caro R, Paz-Ares L, Molina-Pinelo S. Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers 2023;15(5):1466 View
  62. Kamran M, Bhattacharya U, Omar M, Marchionni L, Ince T. ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin. npj Breast Cancer 2022;8(1) View
  63. O’Connor G, Bakker E. Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma. BioMedInformatics 2022;2(4):580 View
  64. Karim S, Iqbal M, Ahmad N, Ansari M, Mirza Z, Merdad A, Jastaniah S, Kumar S. Gene expression study of breast cancer using Welch Satterthwaite t-test, Kaplan-Meier estimator plot and Huber loss robust regression model. Journal of King Saud University - Science 2023;35(1):102447 View
  65. Gao L, Ren R, Shen J, Hou J, Ning J, Feng Y, Wang M, Wu L, Sun Y, Wang H, Wang D, Cao J. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer 2022;22(1) View
  66. Sibilano M, Tullio V, Adorno G, Savini I, Gasperi V, Catani M. Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay. International Journal of Molecular Sciences 2022;23(10):5484 View
  67. Song J, Lin Z, Liu Q, Huang S, Han L, Fang Y, Zhong P, Dou R, Xiang Z, Zheng J, Zhang X, Wang S, Xiong B. MiR‐192‐5p/RB1/NF‐κBp65 signaling axis promotes IL‐10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment. Clinical and Translational Medicine 2022;12(8) View
  68. Mu L, Hu S, Li G, Wu P, Ren C, Lin T, Zhang S, Liang S. Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  69. Rasha F, Boligala G, Yang M, Martinez-Marin D, Castro-Piedras I, Furr K, Snitman A, Khan S, Brandi L, Castro M, Khan H, Jahan N, Almodovar S, Melkus M, Pruitt K, Layeequr Rahman R. Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer. BMC Cancer 2023;23(1) View
  70. Carmona-Rodríguez L, Martínez-Rey D, Martín-González P, Franch M, Sorokin L, Mira E, Mañes S. Superoxide Dismutase-3 Downregulates Laminin α5 Expression in Tumor Endothelial Cells via the Inhibition of Nuclear Factor Kappa B Signaling. Cancers 2022;14(5):1226 View
  71. Wong K, Bateman N, Ng C, Tsang Y, Sun C, Celestino J, Nguyen T, Malpica A, Hillman R, Zhang J, Futreal P, Rojas C, Conrads K, Hood B, Dalgard C, Wilkerson M, Phippen N, Conrads T, Maxwell G, Sood A, Gershenson D. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. Journal of Translational Medicine 2022;20(1) View
  72. Shen X, Mo X, Tan W, Mo X, Li L, Yu F, He J, Deng Z, Xing S, Chen Z, Yang J. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Pathology and Oncology Research 2022;28 View
  73. Luo M, Zhou Y, Gu W, Wang C, Shen N, Dong J, Lei H, Tang Y, Liang Q, Zou J, Xu L, Ma P, Zhuang G, Bi L, Xu L, Zhu L, Chen H, Shen Y. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer Research 2022;82(19):3516 View
  74. Zhang R, Zhao J, Zhao L. TRKB acts as a prognostic predictive marker in Her-2 positive breast cancer. Annals of Diagnostic Pathology 2022;60:152017 View
  75. Allameh A, Hüttmann N, Charlebois E, Katsarou A, Gu W, Gkouvatsos K, Pasini E, Bhat M, Minic Z, Berezovski M, Guido M, Fillebeen C, Pantopoulos K. Hemojuvelin deficiency promotes liver mitochondrial dysfunction and predisposes mice to hepatocellular carcinoma. Communications Biology 2022;5(1) View
  76. Roblek M, Bicher J, van Gogh M, György A, Seeböck R, Szulc B, Damme M, Olczak M, Borsig L, Siekhaus D. The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis. Frontiers in Oncology 2022;12 View
  77. Luo Q, Li J, Su X, Tan Q, Zhou F, Xie S. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer. Frontiers in Genetics 2022;13 View
  78. dos Santos E, Petrone I, Binato R, Abdelhay E. Iroquois Family Genes in Gastric Carcinogenesis: A Comprehensive Review. Genes 2023;14(3):621 View
  79. Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, Zi Y, Gao J, Mu Y, Guan Y, Cao Z, Wang X, Pei Q, Zeng Y, Fan Q, Zeng Z, Ou D, He J, Nie Y, Tan R, Weng L, Li Y, Xiang R, Deng Y, Sun L. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling. Oncogene 2022;41(16):2390 View
  80. Meng L, Zhang L, Xu W. Paxillin is a potential prognostic biomarker associated with immune cell infiltration in ovarian cancer. Heliyon 2023;9(3):e14095 View
  81. Fang X, Zhang T, Chen Z. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma. International Journal of General Medicine 2023;Volume 16:481 View
  82. Dai Y, Kawaguchi T, Nishio M, Otani J, Tashiro H, Terai Y, Sasaki R, Maehama T, Suzuki A. The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor. Genes to Cells 2022;27(11):633 View
  83. Duan Y, Du Y, Gu Z, Zheng X, Wang C. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2022;23(18):10316 View
  84. Luo D, Zeng X, Zhang S, Li D, Cheng Z, Wang Y, Long J, Hu Z, Long S, Zhou J, Zhang S, Zeng Z. Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF ‐β/ SMAD pathway. Journal of Cellular and Molecular Medicine 2023;27(3):456 View
  85. Yang J, Wang Y, Ge R, Jia X, Ge C, Cen Y, Pan D. Overexpression of Copines‐1 is associated with clinicopathological parameters and poor outcome in gastric cancer. Journal of Clinical Laboratory Analysis 2022;36(11) View
  86. Weber F, Schueler-Toprak S, Buechler C, Ortmann O, Treeck O. Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling. Diagnostics 2023;13(5):944 View
  87. Ding J, Yu X, He J, Chen D, Guo F. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity. Frontiers in Genetics 2022;13 View
  88. Skov N, Alves C, Ehmsen S, Ditzel H. Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 2022;23(17):10053 View
  89. Alessandro L, Low K, Abushelaibi A, Lim S, Cheng W, Chang S, Lai K, Sum Y, Maran S. Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer—An Integrated in Silico Approach. International Journal of Molecular Sciences 2022;23(22):14285 View
  90. Bae E, Byun W, Ock C, Kim W, Park H, Lee S. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Biomedicine & Pharmacotherapy 2023;157:114039 View
  91. Tan X, Liu Z, Wang Y, Wu Z, Zou Y, Luo S, Tang Y, Chen D, Yuan G, Yao K. miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death & Disease 2022;13(9) View
  92. Bhattacharyya N, Khan M, Bagabir S, Almalki A, Shahwan M, Haque S, Verma A, Mangangcha I. Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer. Biotechnology and Genetic Engineering Reviews 2023:1 View
  93. Yang Z, Wang H, Zhao Z, Jin Y, Zhang Z, Tan J, Hu F. Gene–microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer. Genes 2022;13(8):1480 View
  94. Ota K, Sakai S, Ohhata T, Suzuki T, Uchida C, Niida H, Kitagawa M. APOBEC3B expression is promoted by lincNMR collaborating with TGF-β–Smad pathway. Carcinogenesis 2023;44(1):1 View
  95. Zhang X, Xu H, Zhang Y, Sun C, Li Z, Hu C, Zhao D, Guo C. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer. Frontiers in Oncology 2022;12 View
  96. Duan H, Chen B, Wang W, Luo H. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. Aging 2023 View
  97. Hua T, Zhao B, Fan S, Zhao C, Kong Y, Tian R, Zhang B. Prognostic implications of PPL expression in ovarian cancer. Discover Oncology 2022;13(1) View
  98. Müller F, Lim J, Bebber C, Seidel E, Tishina S, Dahlhaus A, Stroh J, Beck J, Yapici F, Nakayama K, Torres Fernández L, Brägelmann J, Leprivier G, von Karstedt S. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death & Differentiation 2023;30(2):442 View
  99. Yue H, Tian Y, Wu X, Yang X, Xu P, Zhu H, Sang N. Exploration of the damage and mechanisms of BPS exposure on the uterus and ovary of adult female mice. Science of The Total Environment 2023;868:161660 View
  100. Ren Y, Chen B, Zhang M, Imran A. Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis. BioMed Research International 2023;2023:1 View
  101. Hao H, Guo Z, Li Z, Li J, Jiang S, Fu J, Jiao Y, Deng X, Han S, Li P. Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4. Phytomedicine 2022;106:154409 View
  102. Pescatori S, Leone S, Cipolletti M, Bartoloni S, di Masi A, Acconcia F. Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. Journal of Experimental & Clinical Cancer Research 2022;41(1) View
  103. Xiao Z, Feng X, Zhou Y, Li P, Luo J, Zhang W, Zhou J, Zhao J, Wang D, Wang Y, Tian Z, Zhao X. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma. International Journal of Nanomedicine 2023;Volume 18:95 View
  104. Acconcia F. Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers. International Journal of Molecular Sciences 2022;23(19):11102 View
  105. Harrod A, Lai C, Goldsbrough I, Simmons G, Oppermans N, Santos D, Győrffy B, Allsopp R, Toghill B, Balachandran K, Lawson M, Morrow C, Surakala M, Carnevalli L, Zhang P, Guttery D, Shaw J, Coombes R, Buluwela L, Ali S. Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene 2022;41(44):4905 View
  106. Wang Y, Chen S, Gu D, Yeh Y, Tsai J, Yang K, Jou Y, Chou T, Tang T. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis. Journal of Biomedical Science 2022;29(1) View
  107. Rabelo-Fernández R, Noriega Rivera R, Rivera Y, Tous-Beveraggi J, Valiyeva F, Vivas-Mejia P. Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells. International Journal of Molecular Sciences 2022;23(23):14742 View
  108. Song Y, Wang Z, He L, Sun F, Zhang B, Wang F, Pan J. Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC. Journal of Oncology 2022;2022:1 View
  109. Yang H. Comprehensive Analysis of the Expression and Clinical Significance of a Ferroptosis-Related Genome in Ovarian Serous Cystadenocarcinoma: A Study Based on TCGA Data. Oncologie 2022;24(4):835 View
  110. Grajek J, Kather J, Poleszczuk J. An in silico model to study the impact of carbonic anhydrase IX expression on tumour growth and anti-PD-1 therapy. Journal of The Royal Society Interface 2023;20(198) View
  111. Amjad E, Sokouti B, Asnaashari S. An investigation of 6-Shogaol effects on MCF7 cell lines through a systems biology approach. Egyptian Journal of Medical Human Genetics 2022;23(1) View
  112. Han S, Jin X, Hu T, Chi F. LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway. Oncology Reports 2023;49(3) View
  113. Joshi V, Lakhani S, McCart Reed A. NDRG1 in Cancer: A Suppressor, Promoter, or Both?. Cancers 2022;14(23):5739 View
  114. Geoffroy K, Araripe Saraiva B, Viens M, Béland D, Bourgeois-Daigneault M. Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers. Scientific Reports 2023;13(1) View
  115. Xie D, Chen Y, Wan X, Li J, Pei Q, Luo Y, Liu J, Ye T. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer. Frontiers in Endocrinology 2022;13 View
  116. Wang H, Yuan H, Guo Q, Zeng X, Liu M, Ji R, Chen Z, Guan Q, Zheng Y, Wang Y, Zhou Y. A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression. Cancer Cell International 2023;23(1) View
  117. Zhao X, He Y, Wu Y, Liu T, Wang G. IOFS-SA: An interactive online feature selection tool for survival analysis. Computers in Biology and Medicine 2022;150:106121 View
  118. Yao Y, Ma W, Guo Y, Liu Y, Xia P, Wu X, Chen Y, Wang K, Mei C, Wang G, Li X, Zhang Z, Chen X, Yuan Y. USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. Oncogenesis 2022;11(1) View
  119. Özenver N, Efferth T. Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining. Pharmaceutics 2023;15(2):427 View
  120. Wang C, Jiang X, Qi J, Xu J, Yang G, Mi C. PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration. Frontiers in Genetics 2022;13 View
  121. Yang C, Song D, Zhao F, Wu J, Zhang B, Ren H, Sun Q, Qin S. Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer. Frontiers in Oncology 2022;12 View
  122. Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, Wei B, Eckel-Mahan K, Lorenzi P, Lehner R, Sun K. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight 2023;8(2) View
  123. Talebi A, Rokni P, Kerachian M. Transcriptome analysis of colorectal cancer liver metastasis: The importance of long non-coding RNAs and fusion transcripts in the disease pathogenesis. Molecular and Cellular Probes 2022;63:101816 View
  124. Lodi M, Voilquin L, Alpy F, Molière S, Reix N, Mathelin C, Chenard M, Tomasetto C. STARD3: A New Biomarker in HER2-Positive Breast Cancer. Cancers 2023;15(2):362 View
  125. Shi Y, Zhang W, Dai P, Deng J, Tan L. Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma. Scientific Reports 2022;12(1) View
  126. Cai Y, Zeng R, Peng J, Liu W, He Q, Xu Z, Bai N. The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer. Aging 2022;14(17):7038 View
  127. Xiong F, Guo T, Wang X, Wu G, Liu W, Wang Q, Wang B, Chen Y, Muhammad N. Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma. Disease Markers 2022;2022:1 View
  128. Desai S, Dharavath B, Manavalan S, Rane A, Redhu A, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam M, Banerjee A, Prabhash K, Nair S, Dutt A. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 2022;4(1) View
  129. Cruz-De la Rosa M, Jiménez-Wences H, Alarcón-Millán J, Romero-López M, Castañón-Sánchez C, Salmerón-Bárcenas E, Fernández-Tilapa G. miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer. International Journal of Molecular Sciences 2022;23(13):6993 View
  130. Habiburrahman M, Sutopo S, Wardoyo M. Role of DEK in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review. Critical Reviews in Oncology/Hematology 2023;181:103897 View
  131. Reich L, Leal A, Ellsworth E, Liby K. The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice. International Journal of Molecular Sciences 2023;24(5):4298 View
  132. Baldavira C, Prieto T, Machado-Rugolo J, de Miranda J, de Oliveira L, Velosa A, Teodoro W, Ab’Saber A, Takagaki T, Capelozzi V. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in Oncology 2022;12 View
  133. Qiu P, Jie Y, Ma C, Chen H, Qin Y, Tu K, Wang L, Zhang Z. Paired box 8 facilitates the c-MYC related cell cycle progress in TP53-mutation uterine corpus endometrial carcinoma through interaction with DDX5. Cell Death Discovery 2022;8(1) View
  134. Li H, Cheng F, Su X, Mao S. miR ‐2392 serves as an immunological and prognostic biomarker in hepatocellular carcinoma. Liver International 2022;42(12):2923 View
  135. Yu Y, Yao W, Wang T, Xue W, Meng Y, Cai L, Jian W, Yu Y, Zhang C. FBXL6 depletion restrains clear cell renal cell carcinoma progression. Translational Oncology 2022;26:101550 View
  136. Xu Z, Peng B, Kang F, Zhang W, Xiao M, Li J, Hong Q, Cai Y, Liu W, Yan Y, Peng J. The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer. Frontiers in Cell and Developmental Biology 2022;10 View
  137. Regev O, Kizner M, Roncato F, Dadiani M, Saini M, Castro-Giner F, Yajuk O, Kozlovski S, Levi N, Addadi Y, Golani O, Ben-Dor S, Granot Z, Aceto N, Alon R. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells. Frontiers in Immunology 2022;13 View
  138. Gao E, Wang X, Wang F, Deng S, Xia W, Wang R, Wang X, Zhao X, Qian H, Sheikh N. Systematic Characterization of Expression Patterns and Immunocorrelations of Formin-Like Genes in Breast Cancer. BioMed Research International 2022;2022:1 View
  139. Zhang W, Peng W, Li Y, Pan T, Feng F, Xu J, Zhou X, Kuo C. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  140. Bell H, Huber A, Singhal R, Korimerla N, Rebernick R, Kumar R, El-derany M, Sajjakulnukit P, Das N, Kerk S, Solanki S, James J, Kim D, Zhang L, Chen B, Mehra R, Frankel T, Győrffy B, Fearon E, Pasca di Magliano M, Gonzalez F, Banerjee R, Wahl D, Lyssiotis C, Green M, Shah Y. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metabolism 2023;35(1):134 View
  141. Tkacz M, Tarnowski M, Poniewierska-Baran A, Serwin K, Madej-Michniewicz A, Deskur A, Czerny B, Starzyńska T. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022;12(3):700 View
  142. Lee T, Lee K. ECM1 is associated with endocrine resistance in ER+ breast cancers. Animal Cells and Systems 2022;26(3):99 View
  143. James N, Woodman M, De La Cruz P, Eurich K, Ozsoy M, Schorl C, Hanley L, Ribeiro J. Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways. Frontiers in Immunology 2022;13 View
  144. Hao X, Zhang M, Gu M, Wang Z, Zhou S, Li W, Xu S. Long non-coding RNA BZRAP1-AS1 functions in malignancy and prognosis for non-small-cell lung cancer. PeerJ 2022;10:e13871 View
  145. Wang J, Xia W, Huang Y, Li H, Tang Y, Li Y, Yi B, Zhang Z, Yang J, Cao Z, Zhou J. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. Frontiers in Immunology 2022;13 View
  146. Xing J, Chen W, Chen K, Zhu S, Lin F, Qi Y, Zhang Y, Han S, Rao T, Ruan Y, Zhao S, Yu W, Cheng F. TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers 2022;14(19):4809 View
  147. Ren A, Li Q, Guo Y, Cui X, Wang L, Huo Y, Chen H, Liu H, Huang H. Low expression of lncRNA APTR promotes gastric cancer progression. Translational Oncology 2022;25:101506 View
  148. Chai C, Maran S, Thew H, Tan Y, Rahman N, Cheng W, Lai K, Loh J, Yap W. Predicting Deleterious Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) of HRAS Gene and In Silico Evaluation of Their Structural and Functional Consequences towards Diagnosis and Prognosis of Cancer. Biology 2022;11(11):1604 View
  149. Liu Y, Luo G, Yan Y, Peng J. A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values. Frontiers in Genetics 2022;13 View
  150. King L, Flaus A, Coughlan S, Holian E, Golden A. GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal. HRB Open Research 2022;5:8 View
  151. Liu J, Pan C, Lu R, Zhang S. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells. Bioengineered 2022;13(3):7868 View
  152. Li C, Wang J, Wang W, Xu D, Zhou Y, Sun F, Li Y, Guo F, Ma J, Zhang X, Chang M, Xu B, Ma F, Qian H. Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity. Military Medical Research 2022;9(1) View
  153. Noei-Khesht Masjedi M, Asgari Y, Sadroddiny E. Differential expression analysis in epithelial ovarian cancer using functional genomics and integrated bioinformatics approaches. Informatics in Medicine Unlocked 2023;37:101172 View
  154. Ren Z, Zhao Y, Wang G, Miao L, Zhang Z, Ma L, Teng M, Li Y. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis. Clinica Chimica Acta 2022;531:25 View
  155. Lee H, Chang C, Wu K, Chiang H, Chang Y, Liu L, Huang Y, Hung J, Hsu Y, Wu Y, Tsai Y. The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy. Journal of Personalized Medicine 2022;12(6):902 View
  156. Huang S, Luo Q, Huang J, Wei J, Wang S, Hong C, Qiu P, Li C. A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma. Frontiers in Genetics 2022;13 View
  157. Zhong Y, Li M, Guo S, Li M, Cao Z, Luo X, Liu J, Liang R, Shao Y, Yang Y, Chen X, Wei C, Ling W, Zhu X, Huang Y, Zhang J. Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment. Journal of Oncology 2023;2023:1 View
  158. Duan Y, Du Y, Gu Z, Zheng X, Wang C. Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. Frontiers in Molecular Biosciences 2022;9 View
  159. Timpanaro A, Piccand C, Uldry A, Bode P, Dzhumashev D, Sala R, Heller M, Rössler J, Bernasconi M. Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International Journal of Molecular Sciences 2023;24(3):2601 View
  160. Gao T, Zhao L, Zhang F, Cao C, Fan S, Shi X. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors. World Journal of Surgical Oncology 2022;20(1) View
  161. Pakrashy S, Mandal P, Nanda Goswami J, Dey S, Maiti Choudhury S, Bhattacharya B, Emmerling F, Alasmary F, Dolai M. Bioinformatics and Network Pharmacology of the First Crystal Structured Clerodin: Anticancer and Antioxidant Potential against Human Breast Carcinoma Cell. ACS Omega 2022;7(51):48572 View
  162. Shen Q, Wang R, Liu X, Song P, Zheng M, Ren X, Ma J, Lu Z, Li J. HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer. Cancers 2022;14(16):3855 View
  163. Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, Li D, Wang D, Yang Z, Chen H. Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma. Cancers 2022;14(24):6220 View
  164. Wang J, Wang Q, Guan Y, Sun Y, Wang X, Lively K, Wang Y, Luo M, Kim J, Murphy E, Yao Y, Cai G, Fan D. Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function. Journal of Clinical Investigation 2022;132(19) View
  165. Wang S, Chen Z, Lv H, wang C, Wei H, Yu J. LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Journal of Clinical Laboratory Analysis 2023;37(1) View
  166. Han X, Long W, Liu Y, Xu J. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. Frontiers in Surgery 2022;9 View
  167. Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X, Zhang Y. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Frontiers in Surgery 2022;9 View
  168. Tan K, Wang K, Zhao A, Liu Z, Song W, Cheng Q, Li X, Chen Z, Yuan Y, Yang Z. Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target gene. Medical Oncology 2022;40(1) View
  169. Wu Y, Zhou T, Qian D, Liu X, Xu Y, Hong W, Meng X, Tang H. Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer. ACS Omega 2023;8(2):2780 View
  170. Sucularli C. Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma. Cancer Genetics 2022;268-269:28 View
  171. Nagasaka M, Inoue Y, Yoshida M, Miyajima C, Morishita D, Tokugawa M, Nakamoto H, Sugano M, Ohoka N, Hayashi H. The deubiquitinating enzyme USP17 regulates c‐Myc levels and controls cell proliferation and glycolysis. FEBS Letters 2022;596(4):465 View
  172. Hegedüs L, Livingstone E, Bánkfalvi Á, Viehof J, Enyedi Á, Bilecz Á, Győrffy B, Baranyi M, Tőkés A, Gil J, Marko-Varga G, Griewank K, Zimmer L, Váraljai R, Sucker A, Zaremba A, Schadendorf D, Aigner C, Hegedüs B. The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition. International Journal of Molecular Sciences 2022;23(6):3324 View
  173. Jovanović M, Stanković T, Stojković Burić S, Banković J, Dinić J, Ljujić M, Pešić M, Dragoj M. Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life 2022;12(9):1291 View
  174. Schmitt M, Gallistl J, Schüler-Toprak S, Fritsch J, Buechler C, Ortmann O, Treeck O. Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response. Cancers 2022;14(17):4108 View
  175. Rutherford T, Elder A, Lyons T. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a. Cell Death & Disease 2021;12(10) View
  176. Min J, Ma J, Wang Q, Yu D. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription. Clinics 2022;77:100081 View
  177. Chen Y, Chen C, Chang C, Huang B, Chen Y. Clerodane diterpene induces apoptosis/anoikis and suppresses migration and invasion of human bladder cancer cells through the histone deacetylases, integrin–focal adhesion kinase, and matrix metalloproteinase 9 signalling pathways. Human & Experimental Toxicology 2022;41:096032712211430 View
  178. Alsina-Sanchis E, Mülfarth R, Moll I, Böhn S, Wiedmann L, Jordana-Urriza L, Ziegelbauer T, Zimmer E, Taylor J, De Angelis Rigotti F, Stögbauer A, Giaimo B, Cerwenka A, Borggrefe T, Fischer A, Rodriguez-Vita J. Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages. Cancer Research 2022;82(23):4414 View
  179. Mao J, Wang D, Xu P, Wang Y, Zhang H, Wang S, Xu F, Wang J, Zhang F. Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells. Journal of Medicinal Chemistry 2022;65(24):16451 View
  180. Yan D, Li C, Zhou Y, Yan X, Zhi W, Qian H, Han Y. Exploration of Combinational Therapeutic Strategies for HCC Based on TCGA HCC Database. Oncologie 2022;24(1):101 View
  181. Fang W, Gan Y, Zhang L, Xiong J. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma. Frontiers in Oncology 2022;12 View
  182. Lin C, Yu C, Liu C, Chao T, Huang C, Tseng L, Lai J. CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer. Clinical and Translational Oncology 2022;24(11):2120 View
  183. Zheng Y, Li J, Ning L, Xie N. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Breast Cancer: Targets and Therapy 2022;Volume 14:475 View
  184. Liao Y, Liao Y, Li J, Li Y, Fan Y. The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis. Breast Cancer: Targets and Therapy 2023;Volume 15:135 View
  185. He Y, Li Y, Xiang J, Huang X, Zhao M, Wang Y, Chen R. TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma. Frontiers in Genetics 2022;13 View
  186. Bai B, Liu Y, Fu X, Qin H, Li G, Wang H, Sun S, Cai L. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α). Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  187. Shi H, Zhang Y, Wang Y, Fang P, Liu Y, Li W. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1. Toxicology and Applied Pharmacology 2022;439:115926 View
  188. Acevedo-Díaz A, Morales-Cabán B, Zayas-Santiago A, Martínez-Montemayor M, Suárez-Arroyo I. SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways. Cancers 2022;14(11):2807 View
  189. Huang S, Hou Y, Hu M, Hu J, Liu X. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma. BMC Cancer 2022;22(1) View
  190. Li Y, Liang X, Che G, Chen Y, Luo L, Liu K, Xie R, Zeng L. Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer. Biomolecules 2022;12(10):1533 View
  191. Duan Y, Du Y, Mu Y, Gu Z, Wang C. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma. Frontiers in Molecular Biosciences 2022;9 View
  192. Hong Y, Aziz N, Park J, Lee D, Kim J, Kim S, Choi W, Lee C, Lee H, Huyen Trang H, Kim H, Jeon Y, Kim B, Kim Y, Kim K, Yoo B, Han J, Parameswaran N, Kim J, Hur H, Cho J. The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer. Cancer Letters 2022;544:215803 View
  193. Yadav P, Sharma P, Chetlangia N, Mayalagu P, Karunagaran D. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells. Chemico-Biological Interactions 2022;368:110224 View
  194. Baczewska M, Supruniuk E, Bojczuk K, Guzik P, Milewska P, Konończuk K, Dobroch J, Chabowski A, Knapp P. Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications. International Journal of Molecular Sciences 2022;23(16):8968 View
  195. Li Y, Chen M, Chen Q, Yuan M, Zeng X, Zeng Y, He M, Wang B, Han B. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer. Advances in Therapy 2023;40(4):1456 View
  196. Donovan J, Deng Z, Bian F, Shukla S, Gomez-Arroyo J, Shi D, Kalinichenko V, Kalin T. Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1. Frontiers in Oncology 2023;13 View
  197. Chen Y, Liu R, Ying W, Yang Y, Xiang S, Shao X, Cao J, Zhang Y, Yang B, He Q, Ying M. Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells. Acta Pharmacologica Sinica 2023;44(3):661 View
  198. Liu Y, Hu Y, Deng L, Xu Y. The Underlying Roles of Exosome-Associated PIGR in Fatty Acid Metabolism and Immune Signaling in Colorectal Cancer. Journal of Oncology 2022;2022:1 View
  199. Suo H, Xiao N, Wang K. Potential roles of synaptotagmin family members in cancers: Recent advances and prospects. Frontiers in Medicine 2022;9 View
  200. Sun X, Zhang T. Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer. Frontiers in Genetics 2022;13 View
  201. Shen Y, Huang Q, Ji M, Hsueh C, Zhou L. Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas. BMC Cancer 2022;22(1) View
  202. Paul A, George B, Saini S, Pillai M, Toi M, Costa L, Kumar R. Delineation of Pathogenomic Insights of Breast Cancer in Young Women. Cells 2022;11(12):1927 View
  203. Mehta V, Meena J, Kasana H, Munshi A, Chander H. Prognostic significance of CHAC1 expression in breast cancer. Molecular Biology Reports 2022;49(9):8517 View
  204. Xu Z, Liu S, Feng C, Xu F, Kong D, Mi J, Yang C, Zhang G, Wei P, Orgil B, Bergquist J, Tian G. Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer. Cell Death Discovery 2022;8(1) View
  205. Yang Y, Ye F, Xia T, Wang Q, Du J. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. BMC Cancer 2022;22(1) View
  206. Peng H, Du X, Zhang Y. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2022;9 View
  207. Li C, Yoshimura T, Tian M, Wang Y, Kondo T, Yamamoto K, Fujisawa M, Ohara T, Sakaguchi M, Matsukawa A. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Breast Cancer Research 2022;24(1) View
  208. Sharma P, Yadav P, Sundaram S, Venkatraman G, Bera A, Karunagaran D. HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sciences 2022;304:120727 View
  209. Ramos E, Yang B, Vasquez Y, Lin K, Choudhari R, Gadad S. Characterization of the Testis-specific LINC01016 Gene Reveals Isoform-specific Roles in Controlling Biological Processes. Journal of the Endocrine Society 2021;5(11) View
  210. Lv Z, Wang Q, Liu X, Du Z, Liang W, Liu T, Zheng Y, Ma B, Xue D. Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer. Frontiers in Genetics 2022;13 View
  211. Irshad R, Raj N, Gabr G, Manzoor N, Husain M. Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer. Frontiers in Pharmacology 2022;13 View
  212. Li S, Chen S, Dong Z, Song X, Li X, Huang Z, Li H, Huang L, Zhuang G, Lan R, Guo M, Li W, Saw P, Zhang L. Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer. Acta Pharmaceutica Sinica B 2023;13(3):967 View
  213. Lee H, Chang C, Huang Y, Wu K, Chiang H, Chang Y, Liu L, Hung J, Hsu Y, Wu Y, Tsai Y. Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma. Biology 2022;11(5):760 View
  214. Kang X, Zhao C, Liu Y, Wang G. The phosphorylation level of Cofilin-1 is related to the pathological subtypes of gastric cancer. Medicine 2022;101(43):e31309 View
  215. Zhao J, Guo M, Song Y, Liu S, Liao R, Zhang Y, Zhang Y, Yang Q, Gu Y, Huang X. Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022;12 View
  216. Evers M, Song J, Shriwas P, Greenbaum H, Chen X. From Transcriptomics, Metabolomics to Functional Studies: Extracellular ATP Induces TGF-β-Like Epithelial Mesenchymal Transition in Lung Cancer Cells. Frontiers in Oncology 2022;12 View
  217. Augimeri G, Fiorillo M, Morelli C, Panza S, Giordano C, Barone I, Catalano S, Sisci D, Andò S, Bonofiglio D. The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment. Cancers 2023;15(3):819 View
  218. Li C, Chen S, Liu C, Mo C, Gong W, Hu J, He M, Xie L, Hou X, Tang J, Ou M. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Hereditas 2022;159(1) View
  219. Liu L, Lv Z, Xue X, Xing Z, Zhu F. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers 2022;14(23):5781 View
  220. Lim E, Lim S, Tan K, Sathiya M, Cheng W, Lai K, Loh J, Yap W. In-Silico Analysis of Deleterious SNPs of FGF4 Gene and Their Impacts on Protein Structure, Function and Bladder Cancer Prognosis. Life 2022;12(7):1018 View
  221. Wang C, Cheng B. MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway. Bioengineered 2022;13(3):4869 View
  222. Lin X, Xiao M, Chen Z, Ding C, Zhang T, Li Q, Xu Y. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. Journal of Oncology 2022;2022:1 View
  223. Ji S, Long S, Yang Y, Liu Z, Wang R, Zhang H, Zhang S, Kuo C. Network Pharmacology and Molecular Docking on the Molecular Mechanism of Jiawei-Huang Lian-Gan Jiang Decoction in the Treatment of Colorectal Adenomas. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  224. Pang H, Wang J, Wei Q, Liu J, Chu X, Yuan C, Yang B, Li M, Ma D, Tang Y, Wang C, Zhang J. miR ‐548ag functions as an oncogene by suppressing MOB1B in the development of obesity‐related endometrial cancer. Cancer Science 2023;114(4):1507 View
  225. Akrami S, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma. Computers in Biology and Medicine 2023;157:106529 View
  226. Jin Y, Cao J, Cheng H, Hu X. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma. Journal of Chemotherapy 2023:1 View
  227. Liu B, He X, Wang Y, Huang J, Zheng Y, Li Y, Lu L. Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis. Frontiers in Immunology 2022;13 View
  228. Seeneevassen L, Dubus P, Gronnier C, Varon C. Hippo in Gastric Cancer: From Signalling to Therapy. Cancers 2022;14(9):2282 View
  229. Huang X, Fu L, Cai Q, Fan F. Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma. Frontiers in Oncology 2023;13 View
  230. Poh A, Love C, Chisanga D, Steer J, Baloyan D, Chopin M, Nutt S, Rautela J, Huntington N, Etemadi N, O’Brien M, O’Keefe R, Ellies L, Macri C, Mintern J, Whitehead L, Gangadhara G, Boon L, Chand A, Lowell C, Shi W, Pixley F, Ernst M. Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Science Advances 2022;8(25) View
  231. Ibragimova M, Tsyganov M, Litviakov N. Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis. International Journal of Molecular Sciences 2022;23(22):13906 View
  232. Ju L, Shi Y, Liu G. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. PeerJ 2022;10:e14506 View
  233. Li X, Kang K, Peng Y, Shen L, Shen L, Zhou Y. Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers. Aging 2022;14(22):9221 View
  234. Chen B, Luo Y, Kang X, Sun Y, Jiang C, Yi B, Yan X, Chen Y, Shi R. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes. Frontiers in Genetics 2022;13 View
  235. Li N, Li R, Song B, Ge H, Qu Y, Zhang Z. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the METTL7B Gene. Journal of Oncology 2022;2022:1 View
  236. Wang J, Jin J, Liang Y, Zhang Y, Wu N, Fan M, Zeng F, Deng F. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma. Frontiers in Genetics 2022;13 View
  237. Chen X, Yuan Y, Zhou F, Huang X, Pu J, Niu X, Jiang X, Ding X. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma. Aging 2022;14(19):7866 View
  238. Lin Y, Lin P, Guo W, Huang J, Xu X, Zhuang X. PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer. Environmental Toxicology 2023;38(4):941 View
  239. Fadó R, Zagmutt S, Herrero L, Muley H, Rodríguez-Rodríguez R, Bi H, Serra D, Casals N. To be or not to be a fat burner, that is the question for cpt1c in cancer cells. Cell Death & Disease 2023;14(1) View
  240. Jia Y, Li J, Wu H, Wang W, Sun S, Feng C, Liu X, Li C, Zhang Y, Cai Y, Wei X, Yao P, Liu X, Zhang S, Wu F. Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer. Medicine 2023;102(6):e32927 View
  241. Shen J, Wang M, Li F, Yan H, Wang R, Zhou J. Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer. Breast Cancer: Targets and Therapy 2022;Volume 14:375 View
  242. Lone M, Gul S, Mehraj U, Sofi S, Dar A, Ganie S, Wani N, Mir M, Zargar M. Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors. Applied Biochemistry and Biotechnology 2023 View
  243. Qiu M, Chen M, Lan Z, Liu B, Xie J, Li X. Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2. Bioengineered 2022;13(4):10123 View
  244. Dou X, Wang Z, Lu W, Miao L, Zhao Y. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way. BMC Pulmonary Medicine 2022;22(1) View
  245. Liu W, Zhang F, Yang K, Yan Y, Liu J. Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response. PLOS ONE 2023;18(1):e0280989 View
  246. Li D, Huang S, Luo C, Xu Y, Fu S, Liu K, Wu J. CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma. Current Oncology 2023;30(3):2653 View
  247. Chen Z, Wei Q. Developing an Improved Survival Prediction Model for Disease Prognosis. Biomolecules 2022;12(12):1751 View
  248. Biel T, Petrovskaya S, Mascia F, Ju T, Fashoyin-Aje L, Herremans K, Riner A, Underwood P, Gerber M, Donoghue M, Trevino J, Rao V, Fujiwara K. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. PLOS ONE 2023;18(2):e0281182 View
  249. Quevedo-Ocampo J, Escobedo-Calvario A, Souza-Arroyo V, Miranda-Labra R, Bucio-Ortiz L, Gutiérrez-Ruiz M, Chávez-Rodríguez L, Gomez-Quiroz L. Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?. Technology in Cancer Research & Treatment 2022;21:153303382211444 View
  250. Mori J, White J, Elhussin I, Duduyemi B, Karanam B, Yates C, Wang H. Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients. Frontiers in Oncology 2022;12 View
  251. Hu Y, Xie Q, Chen S, Zhao W, Zhao X, Ruan Q, Zheng Z, Zhao H, Ma T, Guo J, Li L. Par3 promotes breast cancer invasion and migration through pull tension and protein nanoparticle-induced osmotic pressure. Biomedicine & Pharmacotherapy 2022;155:113739 View
  252. Bassiouni R, Idowu M, Gibbs L, Robila V, Grizzard P, Webb M, Song J, Noriega A, Craig D, Carpten J. Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer. Cancer Research 2023;83(1):34 View
  253. Feng Y, Han X, Zhang Z, Qiao H, Tang H. ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. Frontiers in Genetics 2023;13 View
  254. Zhao K, Gao M, Lin M, Niu X. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma. Disease Markers 2022;2022:1 View
  255. Sun X, Ma Q, Cheng Y, Huang H, Qin J, Zhang M, Qu S. Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance. Frontiers in Genetics 2023;14 View
  256. Das A, Prajapati A, Karna A, Sharma H, Uppal S, Lather V, Pandita D, Agarwal P. Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer. Chemico-Biological Interactions 2023;376:110443 View
  257. Kelly M, Wisniewska K, Regner M, Lewis M, Perreault A, Davis E, Phanstiel D, Parker J, Franco H. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer. Nature Communications 2022;13(1) View
  258. Zeng S, Xu Z, Liang Q, Thakur A, Liu Y, Zhou S, Yan Y. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis. Chemico-Biological Interactions 2023;373:110372 View
  259. Wang X, Wu S, Peng Z, Zhu H. SLCO4A1 is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated Immunity in Thyroid Cancer. International Journal of General Medicine 2021;Volume 14:9615 View
  260. Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T, Chen B, Jiang X, Cui R. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Frontiers in Immunology 2022;13 View
  261. Ishikawa A, Fujii H, Fukui T, Kido A, Katsuya N, Sentani K, Kuraoka K, Tazuma S, Sudo T, Serikawa M, Oka S, Oue N. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness. Pathology - Research and Practice 2023;241:154277 View
  262. Lee M, Lee Y, Huang S, Chang C, Ko C, Lee W, Chen T, Tzou S, Huang C, Tai M, Lin Y, Kung M, Tsai M, Chen Y, Chang Y, Wen Z, Huang C, Chu T. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes 2022;13(4):629 View
  263. Satoh K, Sakai S, Nishizuka M. Knockdown of RhoQ, a member of Rho GTPase, accelerates TGF-β-induced EMT in human lung adenocarcinoma. Biochemistry and Biophysics Reports 2022;32:101346 View
  264. Tóth G, Sugár S, Pál D, Fügedi K, Drahos L, Schlosser G, Oláh C, Reis H, Kovalszky I, Szarvas T, Turiák L. Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. Cancers 2022;14(19):4867 View
  265. De Palma F, Carbonnier V, Salvatore F, Kroemer G, Pol J, Maiuri M. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 2022;14(23):5980 View
  266. Sun W, Wang X, Wang D, Lu L, Lin H, Zhang Z, Jia Y, Nie X, Liu T, Fu W. CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer. Journal for ImmunoTherapy of Cancer 2022;10(7):e005063 View
  267. Chu M, Zheng K, Li X, Luo Z, Yang X, Wei C, Andreucci E. Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Analytical Cellular Pathology 2022;2022:1 View
  268. Peng H, Zhu E, Wang J, Du X, Wang C, Yang M, Zhang Y. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Frontiers in Pharmacology 2022;13 View
  269. Dioguardi M, Cantore S, Sovereto D, La Femina L, Caloro G, Spirito F, Scacco S, Di Cosola M, Lo Muzio L, Troiano G, Ballini A. Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis. Life 2022;12(8):1269 View
  270. Wei Q, Miao T, Zhang P, Jiang B, Yan H. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates. Frontiers in Genetics 2022;13 View
  271. Kim D, Jeong J, Lee D, Hyeon D, Park G, Jeon S, Lee K, Jang J, Hwang D, Kim H, Jung K. PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer. Nature Communications 2022;13(1) View
  272. Ouyang Y, Lu W, Wang Y, Wang B, Li F, Li X, Bai Y, Wang Y. Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify the potential mRNA biomarkers in breast cancer. Gene 2023;857:147174 View
  273. Liao H, Li H, Song J, Chen H, Si H, Dong J, Wang J, Bai X. Expression of the prognostic marker IL ‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer. Journal of Clinical Laboratory Analysis 2023;37(3) View
  274. Koyanagi A, Kotani H, Iida Y, Tanino R, Kartika I, Kishimoto K, Harada M. Protective roles of cytoplasmic p21 Cip1 /Waf1 in senolysis and ferroptosis of lung cancer cells. Cell Proliferation 2022;55(12) View
  275. Guo M, Zhuang H, Huang J, Shao X, Bai N, Li M, Niu M, Wei W, Sun L, Li Y, Qiang Z. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression. Molecular and Cellular Biochemistry 2022 View
  276. Hegde M, Daimary U, Jose S, Sajeev A, Chinnathambi A, Alharbi S, Shakibaei M, Kunnumakkara A. Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis. Frontiers in Genetics 2022;13 View
  277. Jin Z, Wu J, Lin J, Wang J, Shen Y. Identification of the Transcription Co-Factor–Related Gene Signature and Risk Score Model for Osteosarcoma. Frontiers in Genetics 2022;13 View
  278. Oh K, Nam A, Bang J, Seo H, Kim J, Yoon J, Kim T, Oh D. A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers. Oncogene 2022;41(32):3939 View
  279. Quinlan P, Figeuredo G, Mongan N, Jordan L, Bray S, Sreseli R, Ashfield A, Mitsch J, van den Ijssel P, Thompson A, Quinlan R. Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP. Cell Stress and Chaperones 2022;27(2):177 View
  280. Angel C, Stafford M, McNally C, Nesbitt H, McKenna D. MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. Cancers 2023;15(4):1291 View
  281. Magrath J, Kang H, Hartono A, Espinosa-Cotton M, Somwar R, Ladanyi M, Cheung N, Lee S. Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein. Frontiers in Cell and Developmental Biology 2022;10 View
  282. Meijuan C, Meng X, Fang L, Qian W. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments. Journal of Ovarian Research 2023;16(1) View
  283. Li Y, Zhang M, Wu L, Liu Y, Zhang Z, Zeng L, Lin N, Zhang C. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD. Journal of Biomedical Science 2022;29(1) View
  284. Tsujimoto G, Ito R, Yoshikawa K, Ueki C, Okada N. NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression. Frontiers in Cell and Developmental Biology 2022;10 View
  285. Le T, Payne S, Buckwald M, Hayes L, Parker S, Burge C, Oudin M. Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3. npj Breast Cancer 2022;8(1) View
  286. Leng R, Meng Y, Sun X, Zhao Y. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes. Frontiers in Oncology 2022;12 View
  287. Li C, Fang C, Chan M, Lu P, Ger L, Chu J, Chang Y, Chen C, Hsiao M. The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers. The Journal of Pathology: Clinical Research 2023;9(3):165 View
  288. Su J, Tian X, Xu W, Anwaier A, Ye S, Zhu S, Wang Y, Gu J, Shi G, Qu Y, Zhang H, Ye D. The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma. Cancers 2022;14(20):4992 View
  289. Dai D, Liu L, Guo Y, Shui Y, Wei Q. A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma. Cancers 2022;15(1):57 View
  290. Zhai Y, Zhang Y, Liu H, Zhang Z. Multi-angle Support Vector Survival Analysis with Neural Tangent Kernel Study. Arabian Journal for Science and Engineering 2023 View
  291. Xu Z, Wang Y, Xu J, Ang X, Ge N, Xu M, Pei C. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining. Heliyon 2023;9(2):e13543 View
  292. Tozuka T, Noro R, Seike M, Honda K. Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability. Cancers 2022;14(18):4363 View
  293. Xu X, Ma L, Zhang X, Guo S, Guo W, Wang Y, Qiu S, Tian X, Miao Y, Yu Y, Wang J. A positive feedback circuit between RN7SK snRNA and m6A readers is essential for tumorigenesis. Molecular Therapy 2022 View
  294. Dioguardi M, Cantore S, Sovereto D, La Femina L, Spirito F, Caloro G, Caroprese M, Maci M, Scacco S, Lo Muzio L, Di Cosola M, Troiano G, Ballini A. Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. Journal of Personalized Medicine 2022;12(9):1436 View
  295. Yang K, Li C, Liu Y, Gu X, Jiang L, Shi L. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer. Cells 2022;11(9):1427 View
  296. Eguchi T, Csizmadia E, Kawai H, Sheta M, Yoshida K, Prince T, Wegiel B, Calderwood S. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration. Cells 2022;11(24):3993 View
  297. Qi L, Wang L, Song F, Ding Z, Zhang Y. The role of miR-4469 as a tumor suppressor regulating inflammatory cell infiltration in colorectal cancer. Computational and Structural Biotechnology Journal 2022;20:3755 View
  298. Zhu X, Zhang Y, Wu Y, Diao W, Deng G, Li Q, Wu C, Falzone L. HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters. International Journal of Genomics 2022;2022:1 View
  299. Pacifico F, Mellone S, D'Incalci M, Stornaiuolo M, Leonardi A, Crescenzi E. Trabectedin suppresses escape from therapy-induced senescence in tumor cells by interfering with glutamine metabolism. Biochemical Pharmacology 2022;202:115159 View
  300. Xu J, Chen S, Liang J, Hao T, Wang H, Liu G, Jin X, Li H, Zhang J, Zhang C, He Y. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Frontiers in Immunology 2022;13 View
  301. Mary C, Soflaee M, Kesavan R, Gelin M, Brown H, Zacharias G, Mathews T, Lemoff A, Lionne C, Labesse G, Hoxhaj G. Crystal structure of human NADK2 reveals a dimeric organization and active site occlusion by lysine acetylation. Molecular Cell 2022;82(17):3299 View
  302. You S, Zhu X, Yang Y, Du X, Song K, Zheng Q, Zeng P, Yao Q, Muthu M. SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells. Journal of Oncology 2022;2022:1 View
  303. Yi Q, Liang Q, Liu Y, Gong Z, Yan Y. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma. Frontiers in Oncology 2022;12 View
  304. Chen S, Xu J, Yin S, Wang H, Liu G, Jin X, Zhang J, Wang H, Wang H, Li H, Liang J, He Y, Zhang C. Identification of a Two-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival in Diffuse-Type Gastric Cancer. Current Oncology 2022;30(1):171 View
  305. Rahmy S, Mishra S, Murphy S, Blagg B, Lu X. Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors. Frontiers in Immunology 2022;13 View
  306. Fang Z, Li C, Wu Z, Hou Y, Wu H, Liu J. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. World Journal of Gastrointestinal Oncology 2022;14(11):2138 View
  307. Mameri H, Buhagiar-Labarchède G, Fontaine G, Corcelle C, Barette C, Onclercq-Delic R, Beauvineau C, Mahuteau-Betzer F, Amor-Guéret M. Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cellular and Molecular Life Sciences 2022;79(8) View
  308. Son S, Kim H, Lim H, Lee J, Lee K, Shin I. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer. Cell Death & Disease 2023;14(2) View
  309. Yuan Y, Zhang X, Du K, Zhu X, Chang S, Chen Y, Xu Y, Sun J, Luo X, Deng S, Qin Y, Feng X, Wei Y, Fan X, Liu Z, Zheng B, Ashktorab H, Smoot D, Li S, Xie X, Jin Z, Peng Y. Circ_CEA promotes the interaction between the p53 and cyclin-dependent kinases 1 as a scaffold to inhibit the apoptosis of gastric cancer. Cell Death & Disease 2022;13(9) View
  310. Malpeli G, Barbi S, Innamorati G, Alloggio M, Filippini F, Decimo I, Castelli C, Perris R, Bencivenga M. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. Journal of Personalized Medicine 2022;12(12):2006 View
  311. Yuan M, Zhai Y, Men Y, Zhao M, Sun X, Ma Z, Yang X, Sun S, Bao Y, Liu Y, Hui Z. Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer. Thoracic Cancer 2022;13(23):3331 View
  312. Yu T, Wu F, Jia Y, Zhang X, Qi X, Jin Z, Hao T, Zhao J, Liu Z, Wang C, Niu M, Yue Q, Li M, Liu Y. RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer. Cell & Bioscience 2022;12(1) View
  313. Bang S, Jee S, Son H, Cha H, Sim J, Kim Y, Park H, Myung J, Kim H, Paik S. Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma. Pathology and Oncology Research 2022;28 View
  314. Yu X, Wang M, Qian J, Wu X. CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  315. Dai Q, Song F, Li X, Huang F, Zhao H. Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma. BMC Cancer 2022;22(1) View
  316. Köhler B, Dubovik S, Hörterer E, Wilk U, Stöckl J, Tekarslan-Sahin H, Ljepoja B, Paulitschke P, Fröhlich T, Wagner E, Roidl A. Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. Cancers 2022;14(22):5554 View
  317. Xu Z, Cai Y, Liu W, Kang F, He Q, Hong Q, Zhang W, Li J, Yan Y, Peng J. Downregulated exosome-associated gene FGF9 as a novel diagnostic and prognostic target for ovarian cancer and its underlying roles in immune regulation. Aging 2022;14(4):1822 View
  318. Wang Y, Zhou D, Kong Y, Yang Q, Ding Y, Wang W, Sheikh N. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. BioMed Research International 2022;2022:1 View
  319. Hu X, Zhou J, Zhang Y, Zeng Y, Jie G, Wang S, Yang A, Zhang M. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. Frontiers in Genetics 2022;13 View
  320. Wu K, Huang Y, Wu Y, Chang C, Chang Y, Chiang H, Liu L, Tsai Y, Hung J. Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming. Biology 2022;11(7):975 View
  321. Zhu C, Wang S, Du Y, Dai Y, Huai Q, Li X, Du Y, Dai H, Yuan W, Yin S, Wang H. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. BMC Gastroenterology 2022;22(1) View
  322. Liu Y, Zhang J, Wang Z, Zhang X, Dai Z, Wu W, Zhang N, Liu Z, Zhang J, Luo P, Wen Z, Yu J, Zhang H, Yang T, Cheng Q. Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 2022;10 View
  323. Konrad S, Schwamborn K, Krüger A, Honert K, Schmitt M, Hellmann D, Schmalfeldt B, Meindl A, Kiechle M, Quante A, Brambs C, Grill S, Ramser J. NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer. Biomarkers in Medicine 2022;16(14):1029 View
  324. Wu Z, Wang Y, Li J, Wang H, Tuo X, Zheng J. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. Frontiers in Genetics 2022;13 View
  325. Wang L, Zeng Q, Jiang S, Chen Z, Wang X, Li L, Li X. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. Frontiers in Oncology 2022;12 View
  326. Montgomery E, Xing E, Campbell M, Li P, Blachly J, Tsung A, Coss C. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022;23(22):13768 View
  327. Wright R, Vastolo V, Oliete J, Carbonell-Caballero J, Beato M. Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Frontiers in Endocrinology 2022;13 View
  328. Zhou C, Chen Z, Xiao B, Xiang C, Li A, Zhao Z, Li H. Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. Frontiers in Cell and Developmental Biology 2022;10 View
  329. Song Y, Ma R. Identifying the Potential Roles of PBX4 in Human Cancers Based on Integrative Analysis. Biomolecules 2022;12(6):822 View
  330. Zhang T, Goel A, Xu X, Wu Y, Tang E, Zhang F, Li Y, Li H, Cai Y, Weng W. N-mytistoyltransferase 1 and 2 are potential tumor suppressors and novel targets of miR-182 in human non-small cell lung carcinomas. Lung Cancer 2022;171:70 View
  331. Cui Z, Wang J, Chen G, Li D, Cheng B, Lai Y, Wu Z. The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression. Frontiers in Oncology 2023;12 View
  332. Savic D, Steinbichler T, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, Ganswindt U, Skvortsov S, Dudás J, Skvortsova I. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis. Cells 2023;12(2):336 View
  333. Zhao M, Fu Y, Liu L, Hou Y, Shi M, Zhou H, Zhang G, Garg R. Identification of Key Drug Targets and Molecular Mechanisms of Curcumae Rhizoma Acting on HBV-Related HCC: Weighted Correlation Network and Network Pharmacological Analyses. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  334. Chung W, Egan S, Xu K. A tumor-suppressive function for Notch3 in the parous mammary gland. Development 2022;149(19) View
  335. Zheng X, Xiuyi L, Zhu L, Xu K, Shi C, Cui L, Ding H. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma. Cancer Management and Research 2021;Volume 13:9329 View
  336. Liu Q, Lian Q, Song Y, Yang S, Jia C, Fang J. Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer. Frontiers in Oncology 2023;13 View
  337. Zhang H, Wang X, Li Y, Bai Y, Li Q, Wang S, Wei Y, Li J, Wen S, Zhao W. The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer. BMC Cancer 2023;23(1) View
  338. Kottorou A, Dimitrakopoulos F, Diamantopoulou G, Kalofonou F, Stavropoulos M, Thomopoulos K, Makatsoris T, Koutras A, Kalofonos H. Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients. Cancers 2023;15(6):1685 View
  339. Pentimalli F, Krstic-Demonacos M, Costa C, Mutti L, Bakker E. Intratumor microbiota as a novel potential prognostic indicator in mesothelioma. Frontiers in Immunology 2023;14 View
  340. Yang J, Li G, Huang Y, Liu Y. Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition. Toxicology and Applied Pharmacology 2023;466:116458 View
  341. Wang S, Liu Y, Li S, Chen Y, Liu Y, Yan J, Wu J, Li J, Wang L, Xiang R, Shi Y, Qin X, Yang S. COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma. Molecular Cancer Research 2023;21(3):199 View
  342. Yao W, Liu H, Xu F, Cai Z, Hang L, Lu M, Zhao Y, Yang C, Zong Y. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma. Frontiers in Genetics 2023;14 View
  343. Meng M, Gao R, Liu Z, Liu F, Du S, Song Y, He J. Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients. Frontiers in Pharmacology 2023;14 View
  344. Schrenk C, Bollmann L, Haist C, Bister A, Wiek C, Wecker M, Roth D, Petzsch P, Köhrer K, Hamacher A, Hanenberg H, Fluegen G, Kassack M. Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International Journal of Molecular Sciences 2023;24(6):5553 View
  345. Wang Y, Liu X, Yu K, Xu S, Qiu P, Zhang X, Wang M, Xu Y. A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer. iScience 2023;26(4):106330 View
  346. Wang G, Shen K, Xiao J, Fan H, Wang Y, Liu K, Zhou X, Cheng Q, Miao Y, Xu Z, Yang L. Long non‐coding RNA LGALS8‐AS1 facilitates PLAGL2‐mediated malignant phenotypes in gastric cancer. The Journal of Gene Medicine 2023 View
  347. Zhu Y, Zhao Y, Wen J, Liu S, Huang T, Hatial I, Peng X, Al Janabi H, Huang G, Mittlesteadt J, Cheng M, Bhardwaj A, Ashfeld B, Kao K, Maeda D, Dai X, Wiest O, Blagg B, Lu X, Cheng L, Wan J, Lu X. Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. Science Immunology 2023;8(81) View
  348. Kątnik E, Gomułkiewicz A, Piotrowska A, Grzegrzółka J, Rusak A, Kmiecik A, Ratajczak-Wielgomas K, Dzięgiel P. BCL11A Expression in Breast Cancer. Current Issues in Molecular Biology 2023;45(4):2681 View
  349. Gong W, Zhang S. YB1 participated in regulating mitochondrial activity through RNA replacement. Frontiers in Oncology 2023;13 View
  350. Soltan M, Eldeen M, Eid R, Alyamani N, Alqahtani L, Albogami S, Jafri I, Park M, Alsharif G, Fayad E, Mohamed G, Osman R, Kim B, Zaki M. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers. Frontiers in Molecular Biosciences 2023;10 View
  351. Sui H, Cui X, Shi C, Yan Z, Li H, Wang F. LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression. Cancer Science 2023 View
  352. Montanaro M, Agostini M, Anemona L, Bonanno E, Servadei F, Finazzi Agrò E, Asimakopoulos A, Ganini C, Cipriani C, Signoretti M, Bove P, Rugolo F, Imperiali B, Melino G, Mauriello A, Scimeca M. ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. International Journal of Molecular Sciences 2023;24(7):6519 View
  353. Fosu K, Quarshie J, Sarpong K, Aikins A. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes. Genes 2023;14(4):800 View
  354. Yan J, Ye G, Shao Y, Zhou H. Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis. Frontiers in Genetics 2023;14 View
  355. Lee S, Jung H, Park J, Ahn J. Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes. International Journal of Molecular Sciences 2023;24(7):6445 View
  356. Fan C, Wang Q, Kuipers T, Cats D, Iyengar P, Hagenaars S, Mesker W, Devilee P, Tollenaar R, Mei H, ten Dijke P. LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation. The EMBO Journal 2023;42(10) View
  357. Selvaraj M, Kaur J, Murugan A. Computational method for aromatase-related proteins using machine learning approach. PLOS ONE 2023;18(3):e0283567 View
  358. Nguyen K, Boehling J, Tran M, Cheng T, Rivera A, Collins-Burow B, Lee S, Drewry D, Burow M. NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Cancers 2023;15(7):2067 View
  359. Huang K, Chen X, Geng Z, Xiong X, Cong Y, Pan X, Liu S, Ge L, Xu J, Jia X. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4. Functional & Integrative Genomics 2023;23(2) View
  360. Váncza L, Horváth A, Seungyeon L, Rókusz A, Dezső K, Reszegi A, Petővári G, Götte M, Kovalszky I, Baghy K. SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer. Cancers 2023;15(7):2037 View
  361. Liu D, Liu Y, Zhu W, Lu Y, Zhu J, Ma X, Xing Y, Yuan M, Ning B, Wang Y, Jia Y. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo–YAP1 pathway. BMC Medicine 2023;21(1) View
  362. Ho T, Sung T, Pan S, Huang W, Hsu K, Hsu J, Lin T, Hsu C, Yang C. The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo. Biomedicine & Pharmacotherapy 2023;162:114667 View
  363. Li J, Liang H, Xiao W, Wei P, Chen H, Chen Z, Yang R, Jiang H, Zhang Y. Whole-exome mutational landscape and molecular marker study in mucinous and clear cell ovarian cancer cell lines 3AO and ES2. BMC Cancer 2023;23(1) View
  364. Wang Y, Zhao H, He Y, Zhang P, Zeng C, Du T, Shen Q, Chen Y, Zhao S. IKZF4 acts as a novel tumor suppressor in non–small cell lung cancer by suppressing Notch signaling pathway. Cellular Signalling 2023;107:110679 View
  365. Gounou C, Bouvet F, Liet B, Prouzet‐Mauléon V, d'Agata L, Harté E, Argoul F, Siegfried G, Iggo R, Khatib A, Bouter A. Annexin‐A5 and annexin‐A6 silencing prevents metastasis of breast cancer cells in zebrafish. Biology of the Cell 2023 View
  366. Tomas Bort E, Joseph M, Wang Q, Carter E, Roth N, Gibson J, Samadi A, Kocher H, Simoncelli S, McCormick P, Grose R. Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion. eLife 2023;12 View
  367. Nandi I, Smith H, Sanguin-Gendreau V, Ji L, Pacis A, Papavasiliou V, Zuo D, Nam S, Attalla S, Kim S, Lusson S, Kuasne H, Fortier A, Savage P, Martinez Ramirez C, Park M, Katzenellenbogen J, Katzenellenbogen B, Muller W. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression. Journal of Clinical Investigation 2023;133(7) View
  368. Jiang Y, Song L, Lin Y, Nowialis P, Gao Q, Li T, Li B, Mao X, Song Q, Xing C, Zheng G, Huang S, Jin L. ROS-mediated SRMS activation confers platinum resistance in ovarian cancer. Oncogene 2023;42(20):1672 View
  369. Ding J, Ji X, Liu L, Chen D, Luo N, Yu X, Guo F. A prognostic and immunological analysis of 7B-containing Kelch structural domain (KLHDC7B) in pan-cancer: a potential target for immunotherapy and survival. Journal of Cancer Research and Clinical Oncology 2023 View
  370. Lucà S, Franco R, Napolitano A, Soria V, Ronchi A, Zito Marino F, Della Corte C, Morgillo F, Fiorelli A, Luciano A, Palma G, Arra C, Battista S, Cerchia L, Fedele M. PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype. Cancers 2023;15(7):2190 View
  371. Ghannoum S, Fantini D, Zahoor M, Reiterer V, Phuyal S, Leoncio Netto W, Sørensen Ø, Iyer A, Sengupta D, Prasmickaite L, Mælandsmo G, Köhn-Luque A, Farhan H, Merks R. A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression. PLOS Computational Biology 2023;19(4):e1010995 View
  372. Cipolletti M, Leone S, Bartoloni S, Acconcia F. A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma. Frontiers in Endocrinology 2023;14 View
  373. Fu B, Zhou M, Song G, Zeng H, Gong Y, Jiang Y, Ke Y, Huang D, Peng H, Li Q. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma. Aging 2023;15(7):2734 View
  374. Zhang K, Yue B, Duan X, Chen W, Dai X, Chen Y, Li X, Lu J. Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer. Pathology - Research and Practice 2023;245:154462 View
  375. Jeong Y, Knutsdottir H, Shojaeian F, Lerner M, Wissler M, Henriet E, Ng T, Datta S, Navarro-Serer B, Chianchiano P, Kinny-Köster B, Zimmerman J, Stein-O’Brien G, Gaida M, Eshleman J, Lin M, Fertig E, Ewald A, Bader J, Wood L. Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion. Journal of Clinical Investigation 2023;133(8) View
  376. Su L, Zhang F, Liu M, Li H, Li Q, Zhu Y, Hou Y, Chen X, Wang X, Qian C, Yao C, Wang L, Jiao X, Zhu X, Xu Z, Zou C. The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer. Journal of Ethnopharmacology 2023;313:116491 View
  377. Vishnubalaji R, Alajez N. Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes. Cells 2023;12(8):1182 View
  378. Ding Y, Gong Y, Zeng H, Zhou X, Yu Z, Pan J, Zhou M, Liu S, Lai W. Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma. Aging 2023;15(7):2631 View
  379. Fan K, Zhang B, Han D, Sun Y. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. BMC Bioinformatics 2023;24(1) View
  380. Fu L, Lu K, Jiao Q, Chen X, Jia F. The Regulation and Double-Edged Roles of the Deubiquitinase OTUD5. Cells 2023;12(8):1161 View
  381. Murthy D, Attri K. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023;24(8):7304 View
  382. Kang E, Kim H, Lee H, Han W. Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation. Scientific Reports 2023;13(1) View
  383. Ju M, Jang E, Kang S, Roh Y, Jeong J, Han S. Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023;Volume 10:643 View
  384. Contreras-Sanzón E, Carlos-Reyes Á, Sierra-Martínez M, Acosta-Altamirano G, Luna-Rivero C, Núñez-Corona D, García-Hernández A, Ibarra-Sierra E, Vidrio-Morgado H, Alvarez-Sánchez M, Marchat L, López-Camarillo C. Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicry. Translational Oncology 2023;33:101680 View
  385. He J, Jiang X, Yu M, Wang P, Fu L, Zhang G, Cai H. MTF1 has the potential as a diagnostic and prognostic marker for gastric cancer and is associated with good prognosis. Clinical and Translational Oncology 2023 View
  386. Guo L, An T, Zhou H, Wan Z, Huang Z, Chong T. MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment. Scientific Reports 2023;13(1) View
  387. Dai X, Cai L, Zhang Z, Li J. SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity. BMC Cancer 2023;23(1) View
  388. Piñeiro-Hermida S, Bosso G, Sánchez-Vázquez R, Martínez P, Blasco M. Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts. Cell Death & Differentiation 2023 View
  389. Cao L, Chen Y, Xu S, Cheng H. Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?. Frontiers in Oncology 2023;13 View
  390. Xie H, Chen J, Ma C, Zhao J, Cui M. UBP43 promotes epithelial ovarian carcinogenesis via activation of β ‐catenin signaling pathway. Cell Biology International 2023 View
  391. Walakira A, Skubic C, Nadižar N, Rozman D, Režen T, Mraz M, Moškon M. Integrative computational modeling to unravel novel potential biomarkers in hepatocellular carcinoma. Computers in Biology and Medicine 2023;159:106957 View
  392. He Y, Xiang J, Li Y, Huang W, Gu F, Wang Y, Chen R. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment. Cancer Medicine 2023 View
  393. Cai J, Shen W, Zhang G, Li X, Shen H, Li W, Tan C, Zhang T, Shi M, Yang Z, Li Y, Liu H, Zhao X. Xiao Chai Hu Tang alleviates the pancreatic tumorigenesis via improving the mtDNA N6-Methyladenine modification mediated mitochondrial dysfunction in Syrian hamster model. Phytomedicine 2023;116:154840 View
  394. Thippana M, Dwivedi A, Das A, Palanisamy M, Vindal V. Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis. Proteins: Structure, Function, and Bioinformatics 2023 View
  395. Soltan M, Eldeen M, Sajer B, Abdelhameed R, Al-Salmi F, Fayad E, Jafri I, Ahmed H, Eid R, Hassan H, Al-Shraim M, Negm A, Noreldin A, Darwish K. Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. Biology 2023;12(4):613 View
  396. Ngule C, Hemati H, Ren X, Obaleye O, Akinyemi A, Oyelami F, Xiong X, Song J, Liu X, Yang J. Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer. Biomedicines 2023;11(4):1223 View
  397. Yang C, Guo W, Wang Y, Hu L, Wang J, Luo J, Yao X, Liu S, Tao L, Sun L, Lin L. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway. Journal of Ethnopharmacology 2023;314:116566 View
  398. Atalay Şahar E, Ballar Kirmizibayrak P. Differential Expression and Function of SVIP in Breast Cancer Cell Lines and In Silico Analysis of Its Expression and Prognostic Potential in Human Breast Cancer. Cells 2023;12(10):1362 View
  399. Cao J, Liu L, Xue L, Luo Y, Liu Z, Guo J. Long non-coding RNA TTTY14 promotes cell proliferation and functions as a prognostic biomarker in testicular germ cell tumor. Heliyon 2023;9(5):e16082 View
  400. Chen M, Zheng W, Fang L. Identifying liver metastasis-related hub genes in breast cancer and characterizing SPARCL1 as a potential prognostic biomarker. PeerJ 2023;11:e15311 View
  401. Shuvalov O, Kirdeeva Y, Fefilova E, Netsvetay S, Zorin M, Vlasova Y, Fedorova O, Daks A, Parfenyev S, Barlev N. 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells. Metabolites 2023;13(5):656 View
  402. Wu J, Yang F, Zhao M, Xiao H, Chen Y, Liu X, Zheng D. Antler-derived microRNA PC-5p-1090 inhibits HCC cell proliferation, migration, and invasion by targeting MARCKS, SMARCAD1, and SOX9. Functional & Integrative Genomics 2023;23(2) View
  403. Singh P, Rathi A, Minocha R, Sinha A, Haque M, Hassan M, Dohare R. Breast Cancer Prognostic Hub Genes Identified by Integrated Transcriptomic and Weighted Network Analysis: A Road Toward Personalized Medicine. OMICS: A Journal of Integrative Biology 2023;27(5):227 View
  404. Rathbun L, Magliocco A, Bamezai A. Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma. Oncotarget 2023;14(1):426 View
  405. Bu J, Zhang Y, Wu S, Li H, Sun L, Liu Y, Zhu X, Qiao X, Ma Q, Liu C, Niu N, Xue J, Chen G, Yang Y, Liu C. KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nature Communications 2023;14(1) View
  406. Shi Y, Yan J, Liu W, Deng J. Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity. BMC Cancer 2023;23(1) View
  407. Di Matteo A, Belloni E, Pradella D, Chiaravalli A, Pini G, Bugatti M, Alfieri R, Barzan C, Franganillo Tena E, Bione S, Terenzani E, Sessa F, Wyatt C, Vermi W, Ghigna C. Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. International Journal of Molecular Sciences 2023;24(9):8102 View
  408. Yan P, Cheng M, Wang L, Zhao W. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach. International Immunopharmacology 2023;119:110263 View
  409. Duan Y, Zhang X, Ying H, Xu J, Yang H, Sun K, He L, Li M, Ji Y, Liang T, Bai X. Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. Oncogene 2023 View
  410. Deng C, Peng J, Yuan C, Li H, Li W, Chu H, Wei H, He Y, Zeng L, Huo M, Zhang C. Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network. Frontiers in Molecular Biosciences 2023;10 View
  411. Laskar F, Bappy M, Hossain M, Alam Z, Afrin D, Saha S, Ali Zinnah K, Liu Z. An In silico Approach towards Finding the Cancer-Causing Mutations in Human MET Gene. International Journal of Genomics 2023;2023:1 View
  412. Nam J, Schirmer A, Loh C, Drewry D, Macias E. Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro. Cancers 2023;15(10):2817 View
  413. Tan W, Zhang J, Deng Z, Dai F, Tang L, Hu W, Liu H. Pan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer. Cancer Medicine 2023 View
  414. Labat-de-Hoz L, Rubio-Ramos A, Correas I, Alonso M. The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers. Cancers 2023;15(10):2801 View
  415. Zhu Y, Hu Y, Wang P, Dai X, Fu Y, Xia Y, Sun L, Ruan S. Comprehensive bioinformatics and experimental analysis of SH3PXD2B reveals its carcinogenic effect in gastric carcinoma. Life Sciences 2023:121792 View